Ângelo Maiolino

Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study

Shaji Kumar, J H Lee, Juan José Lahuerta et al. · Leukemia · 2011 · 721 citations

Medicine, Hematology, Pharmacotherapy +15

Isatuximab, carfilzomib, and dexamethasone in relapsed multiple myeloma (IKEMA): a multicentre, open-label, randomised phase 3 trial

Philippe Moreau, Meletios Α. Dimopoulos, Joseph Mıkhael et al. · The Lancet · 2021 · 380 citations

Medicine, Pharmacology, Pharmacotherapy +12

Fusarium Infection in Hematopoietic Stem Cell Transplant Recipients

Márcio Nucci, Kieren A. Marr, Flávio Queiroz‐Telles et al. · Clinical Infectious Diseases · 2004 · 330 citations · Full text

Medicine, Hematology, Infectious Diseases +14

Outcome predictors of 84 patients with hematologic malignancies and <i>Fusarium</i> infection

Márcio Nucci, Elias Anaissie, Flávio Queiroz‐Telles et al. · Cancer · 2003 · 309 citations · Full text

Medicine, Hematology, Oncology +12

Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial

Meletios Α. Dimopoulos, Francesca Gay, Fredrik Schjesvold et al. · The Lancet · 2018 · 236 citations · Full text

Medicine, Hematology, Pharmacotherapy +15